| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
COO And CFO | COO, CFO And Secretary | COO, CFO And Secretary +1 more
2 companies
York Charles N II is a COO And CFO at Day One Biopharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 6 buys and 8 sells.
Estimated insider holdings value: $9.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2022 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO And Secretary | Sell | 10,000 | $23.25 | $232,484.32 | -1.6% | -10.6% | -41.2% | |
| Aug 16, 2022 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO And Secretary | Sale+OE | 1,089 | $24.31 | $26,473.59 | -0.3% | -9.2% | -44.5% | |
| Aug 4, 2022 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO And Secretary | Sell | 10,000 | $20.05 | $200,541.00 | -3.0% | -4.6% | -36.9% | |
| Jul 18, 2022 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO And Secretary | Sell | 2,500 | $20.00 | $50,000.00 | -0.7% | +8.5% | -36.3% | |
| Jul 8, 2022 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO And Secretary | Sell | 1,416 | $20.00 | $28,320.00 | -0.4% | +4.6% | -40.9% | |
| Jul 5, 2022 | DAWN Day One Biopharmaceuticals, Inc. | COO, CFO And Secretary | Sell | 2,279 | $20.00 | $45,580.00 | -0.3% | +3.9% | -39.0% | |
| Dec 5, 2017 | SYRE Spyre Therapeutics, Inc. | Chief Financial Officer And VP | Buy | 25,959 | $4.48 | $116,222.95 | +27.9% | - | - |